Rxsight Financial Statements From 2010 to 2026

RXST Stock  USD 8.69  0.22  2.47%   
Analyzing historical trends in various income statement and balance sheet accounts from Rxsight's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Rxsight's valuation are summarized below:
Gross Profit
106.5 M
Profit Margin
(0.25)
Market Capitalization
366.3 M
Enterprise Value Revenue
1.1164
Revenue
142.1 M
There are currently one hundred twenty trending fundamental ratios for Rxsight that can be evaluated and compared over time across competitors. All traders should check out Rxsight's recent fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 676.8 M in 2026. Enterprise Value is likely to drop to about 685.3 M in 2026

Rxsight Total Revenue

168.96 Million

Check Rxsight financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rxsight's main balance sheet or income statement drivers, such as Tax Provision of 30.8 K, Net Interest Income of 11.4 M or Interest Income of 11.4 M, as well as many indicators such as Price To Sales Ratio of 10.43, Dividend Yield of 0.0 or PTB Ratio of 2.34. Rxsight financial statements analysis is a perfect complement when working with Rxsight Valuation or Volatility modules.
  
Build AI portfolio with Rxsight Stock
Check out the analysis of Rxsight Correlation against competitors.
For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.

Rxsight Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets193.4 M366.3 M153.5 M
Slightly volatile
Short and Long Term Debt Total18.9 M11.1 M13 M
Slightly volatile
Other Current Liabilities11.5 M19.8 M8.1 M
Slightly volatile
Total Current Liabilities17.4 M29.8 M12.9 M
Slightly volatile
Other Liabilities130.6 M123.2 M166.8 M
Slightly volatile
Property Plant And Equipment Net19.1 M27.2 M19.1 M
Very volatile
Current Deferred Revenue3.8 M3.6 M1.1 M
Slightly volatile
Accounts Payable2.9 M5.2 M2.6 M
Slightly volatile
Cash15.5 M19.2 M11.2 M
Slightly volatile
Non Current Assets Total20.2 M28.5 M20.1 M
Very volatile
Non Currrent Assets Other601.9 K324 K840.4 K
Slightly volatile
Other Assets1.1 M1.8 M1.1 M
Slightly volatile
Cash And Short Term Investments142.9 M272.8 M113 M
Slightly volatile
Net Receivables36.3 M34.6 M8.7 M
Slightly volatile
Common Stock Total Equity23.9 K25.2 K38 M
Slightly volatile
Common Stock Shares Outstanding30.5 M44.7 M24.3 M
Slightly volatile
Short Term Investments127.4 M253.6 M101.8 M
Slightly volatile
Liabilities And Stockholders Equity193.4 M366.3 M153.5 M
Slightly volatile
Non Current Liabilities Total9.8 M10.3 M268.9 M
Slightly volatile
Capital Lease Obligations14.8 M14.1 M6.8 M
Slightly volatile
Inventory14.3 M25.3 M10.7 M
Slightly volatile
Other Current Assets3.3 M5.2 M2.4 M
Slightly volatile
Other Stockholder Equity554.2 MB302.6 M
Slightly volatile
Total Liabilities31.9 M33.6 M281.7 M
Slightly volatile
Property Plant And Equipment Gross59.2 M56.4 M25.7 M
Slightly volatile
Total Current Assets173.2 M337.9 M133.4 M
Slightly volatile
Capital Stock34.2 K36 K38 M
Slightly volatile
Net Working Capital155.8 M308.1 M120.5 M
Slightly volatile
Short Term Debt1.6 M1.1 M1.2 M
Slightly volatile
Common Stock34.2 K36 K38 M
Slightly volatile
Property Plant Equipment11.8 M9.1 M16.1 M
Slightly volatile
Long Term Debt39.6 M46.2 M30.5 M
Slightly volatile
Long Term Debt Total34.7 M39.1 M42.6 M
Slightly volatile
Capital Surpluse689.4 M731.4 M631.7 M
Slightly volatile
Non Current Liabilities Other110.5 K146.1 K83.5 K
Slightly volatile

Rxsight Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision30.8 K57.5 K27.8 K
Slightly volatile
Interest Income11.4 M10.9 M3.7 M
Slightly volatile
Depreciation And Amortization3.2 M3.3 M3.9 M
Slightly volatile
Interest Expense22.9 K24.1 K751.4 K
Slightly volatile
Selling General Administrative122.5 M116.6 M39.6 M
Slightly volatile
Total Revenue169 M160.9 M39.3 M
Slightly volatile
Other Operating Expenses110.4 M203.3 M79.4 M
Slightly volatile
Research Development30.3 M39.5 M29.5 M
Pretty Stable
Cost Of Revenue25.5 M47.1 M14.6 M
Slightly volatile
Total Operating Expenses84.9 M156.2 M64.8 M
Slightly volatile
Reconciled Depreciation3.2 M3.3 M3.9 M
Slightly volatile
Income Tax Expense30.8 K57.5 K27.8 K
Slightly volatile
Non Operating Income Net Other1.7 M1.4 M2.4 M
Slightly volatile

Rxsight Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation29.7 M28.3 M9.9 M
Slightly volatile
Begin Period Cash Flow16.7 M9.4 M37.5 M
Slightly volatile
Depreciation3.2 M3.3 M3.9 M
Slightly volatile
Capital Expenditures3.9 M6.3 MM
Pretty Stable
Total Cash From Financing Activities148.9 M141.8 M38.7 M
Slightly volatile
End Period Cash Flow16.3 M20.1 M12 M
Slightly volatile
Dividends Paid514.4 K578.7 K631.7 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio10.4310.9885.2872
Slightly volatile
Days Sales Outstanding95.5990.14110
Slightly volatile
Stock Based Compensation To Revenue0.190.21.3008
Slightly volatile
Capex To Depreciation0.721.350.9892
Very volatile
EV To Sales10.410.9584.7969
Slightly volatile
Inventory Turnover1.351.681.072
Slightly volatile
Days Of Inventory On Hand296225469
Slightly volatile
Payables Turnover7.048.124.9759
Slightly volatile
Research And Ddevelopement To Revenue0.270.288.0104
Slightly volatile
Capex To Revenue0.04250.04471.1012
Slightly volatile
Cash Per Share3.645.494.3813
Pretty Stable
Days Payables Outstanding69.3646.54134
Slightly volatile
Current Ratio11.1513.0610.6485
Very volatile
Receivables Turnover3.494.193.4926
Slightly volatile
Capex Per Share0.140.160.1772
Slightly volatile
Revenue Per Share3.43.241.0216
Slightly volatile
Interest Debt Per Share0.350.360.5492
Slightly volatile
Debt To Assets0.04220.04440.087
Pretty Stable
Operating Cycle392316579
Slightly volatile
Days Of Payables Outstanding69.3646.54134
Slightly volatile
Quick Ratio10.2612.089.802
Very volatile
Net Income Per E B T0.80.90.9823
Slightly volatile
Cash Ratio1.120.740.9689
Very volatile
Cash Conversion Cycle323269445
Slightly volatile
Days Of Inventory Outstanding296225469
Slightly volatile
Days Of Sales Outstanding95.5990.14110
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.91.191.0993
Very volatile
Fixed Asset Turnover5.65.331.791
Slightly volatile
Debt Ratio0.04220.04440.087
Pretty Stable
Price Sales Ratio10.4310.9885.2872
Slightly volatile
Asset Turnover0.210.40.137
Slightly volatile

Rxsight Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap676.8 M1.2 B508.8 M
Slightly volatile
Enterprise Value685.3 M1.2 B524.9 M
Slightly volatile

Rxsight Fundamental Market Drivers

Forward Price Earnings116.2791
Cash And Short Term Investments237.2 M

Rxsight Upcoming Events

4th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Rxsight Financial Statements

Rxsight shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Rxsight investors may analyze each financial statement separately, they are all interrelated. The changes in Rxsight's assets and liabilities, for example, are also reflected in the revenues and expenses on on Rxsight's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue3.6 M3.8 M
Total Revenue160.9 M169 M
Cost Of Revenue47.1 M25.5 M
Stock Based Compensation To Revenue 0.20  0.19 
Research And Ddevelopement To Revenue 0.28  0.27 
Capex To Revenue 0.04  0.04 
Revenue Per Share 3.24  3.40 
Ebit Per Revenue(0.24)(0.25)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.